Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepetazone post-operative analgesia phase 3 trial
CTR20150299Phase 3Active
- Sponsor
- Chengdu Medeson Pharmaceutical Biotechnology
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Meptid in postoperative pain, sponsored by Chengdu Medeson Pharmaceutical Biotechnology. Started May 2015; status: active.
02
Drugs
Meptid
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20150299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150299.